from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1275/lprC

LFCtreatmentdescriptionclass of inhibitor

-1.625

Amikacinug/mL Amikacintranslation

-1.507

Cap5-10ug/mL Capreomycintranslation

-2.476

Rox10-50 ug/mL Roxithromycintranslation

0.249

SM2-5 ug/mL Streptomycintranslation

-2.066

Tet5-10 ug/mL Tetracyclinetranslation

-0.500

Rif0.2-5ug/mL Rifampicintranscription

0.139

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.590

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.135

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.612

CPZ10-50 ug/mL Chlorpromazinerespiration

0.929

Clofazimine10-13 ug/mL Clofaziminerespiration

0.420

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.326

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.184

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.186

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.816

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.117

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.741

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.280

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.699

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.108

KCN5-20 ug/mL Potassium cyaniderespiration

0.068

NaN30.2-2 mM Sodium aziderespiration

0.132

Nigericin50 uM Nigericinrespiration

-0.295

TRC10-150 ug/mL Triclosanrespiration

-0.112

TRZ10-25 ug/mL Thioridazinerespiration

-1.773

Valinomycin0.5-10 uM Valinomycinrespiration

0.553

ZnSO42 mM ZnSO4respiration

0.745

menadione6-10 ug/mL Menadionerespiration

1.008

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.379

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.564

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.224

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.388

NRP_1Non-replicating persistence stage 1dosRassociated

0.595

Amp0.2mg/mL AmpicillincellWall

0.450

Cephalexin20-100 ug/mL CephalexincellWall

0.383

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.041

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.117

EMB10-20 ug/mL EthambutolcellWall

0.533

Eta12-40 ug/mL EthionamidecellWall

0.751

INH0.2-0.4 ug/mL IsoniazidcellWall

0.300

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.397

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.085

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.301

BZA0.12 mg/mL BenzamidearomaticAmides

-0.364

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.284

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.490

H2O24 mM hydrogen peroxideDNAdamaging

0.747

Levo10 ug/mL LevofloxacinDNAdamaging

0.155

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.611

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.088

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.096

UVUV-irradiationDNAdamaging

1.400

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.010

Antimycin12.5-50 ug/mL Antimycin A?

0.256

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.009

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.294

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.426

PA8240.2-2 ug/mL PA-824?

-0.799

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.011

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.543

Verapamil50 uM Verapamil?

0.340

mercaptoethanol2 mM 2-Mercaptoethanol?

0.315

methoxatin10-20 ug/mL Methoxatin?